NAD+ Benefits: Complete Guide to What the Science Actually Shows

Key Takeaways

• NAD+ levels decline significantly with age, and restoring them may slow several markers of biological aging
• Clinical trials show NAD+ precursors (NMN and NR) safely raise blood NAD+ levels in humans at doses of 250–2,000 mg/day
• The strongest human evidence supports benefits for cellular energy, metabolic health, and inflammation reduction
• IV NAD+ therapy delivers the molecule directly to your bloodstream, while oral precursors like NMN and NR take an indirect route

Table of Contents

• What Is NAD+ and Why Does It Matter?
• How NAD+ Declines With Age
• The 7 Evidence-Based Benefits of NAD+
• NAD+ Delivery Methods: IV vs. Oral Precursors
• Who Benefits Most From NAD+ Therapy?
• How NAD+ Fits Into Peptide Therapy
• FAQ
• Sources

What Is NAD+ and Why Does It Matter?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell. It plays a direct role in over 500 enzymatic reactions, making it one of the most active molecules in human biology [1].

If you’re exploring peptide therapy for anti-aging or performance, NAD+ deserves your attention. It sits at the intersection of energy production, DNA repair, and cellular communication — three processes that determine how well you age.

NAD+ works primarily through two mechanisms. First, it shuttles electrons during cellular metabolism, driving the production of ATP (your cells’ energy currency) inside mitochondria. Second, it serves as a substrate for enzymes called sirtuins and PARPs, which regulate DNA repair, gene expression, and inflammatory responses [2].

Without enough NAD+, these systems slow down. And they do slow down — predictably, measurably — as you get older.

How NAD+ Declines With Age

NAD+ levels don’t hold steady across your lifespan. Research shows they drop substantially between young adulthood and middle age, with some estimates suggesting a 50% decline by age 50 [3].

This decline isn’t just a number on a lab report. Lower NAD+ correlates with reduced mitochondrial function, increased inflammation, impaired DNA repair capacity, and greater susceptibility to age-related diseases [4]. The relationship between NAD+ depletion and aging has become one of the most studied areas in longevity science.

Several factors accelerate NAD+ loss beyond normal aging:

• Chronic inflammation — activates CD38, an enzyme that consumes NAD+ [5]
• Metabolic stress — obesity and insulin resistance increase NAD+ consumption
• Poor sleep — disrupts circadian regulation of NAD+ synthesis
• Excessive alcohol — directly depletes NAD+ through metabolic processing
• DNA damage — from UV exposure, pollution, or oxidative stress activates PARP enzymes that consume NAD+

Understanding this decline is what drives interest in anti-aging peptide strategies and NAD+ restoration specifically.

The 7 Evidence-Based Benefits of NAD+

1. Cellular Energy Production

NAD+ is required for mitochondria to convert nutrients into ATP. When NAD+ levels are restored in aging cells, mitochondrial function improves measurably.

A 2022 study in npj Aging found that 250 mg/day of NMN supplementation for 12 weeks increased blood NAD+ levels and improved muscle function in healthy men over 65 [6]. Participants showed better grip strength and walking speed compared to placebo.

This connects directly to why many people seek peptides for energy — fatigue often traces back to mitochondrial decline, and NAD+ sits at the center of that machinery.

2. DNA Repair and Genomic Stability

Every day, your cells accumulate tens of thousands of DNA lesions from normal metabolic activity. Repairing this damage requires PARP enzymes, and PARPs require NAD+ as fuel [7].

When NAD+ is depleted, DNA repair slows. Unrepaired damage accumulates, driving cellular aging and increasing cancer risk. Restoring NAD+ levels reactivates this repair capacity.

A systematic review covering 147 studies (113 preclinical, 34 clinical) found favorable outcomes for NAD+ precursors across conditions linked to oxidative stress and impaired DNA repair [1].

3. Sirtuin Activation and Longevity Pathways

Sirtuins are a family of seven proteins that regulate aging, metabolism, and stress resistance. They’re sometimes called “longevity genes,” though that’s an oversimplification.

What’s not an oversimplification: sirtuins are completely dependent on NAD+ to function. No NAD+, no sirtuin activity [8].

SIRT1 and SIRT3 are particularly relevant. SIRT1 influences fat metabolism, inflammation, and insulin sensitivity. SIRT3 protects mitochondria from oxidative damage. Both become less active as NAD+ drops with age.

4. Reduced Inflammation

Chronic low-grade inflammation — sometimes called “inflammaging” — is a hallmark of biological aging. NAD+ helps regulate inflammatory responses through sirtuin-mediated pathways.

A 2025 randomized controlled trial published in eClinicalMedicine tested nicotinamide riboside (1,000 mg/day for 12 weeks) in long-COVID patients. NR supplementation reduced inflammatory markers and supported neurological function compared to placebo [9].

This anti-inflammatory action is one reason NAD+ therapy pairs well with other recovery-focused approaches like peptides for inflammation.

5. Cardiovascular Support

Preclinical studies consistently show NAD+ restoration improves cardiovascular markers — better endothelial function, reduced arterial stiffness, and improved cardiac output [3].

In humans, the data is earlier-stage but promising. A pilot study of 30 patients with stable heart failure found that NR at 1,000 mg twice daily was safe, well-tolerated, and approximately doubled whole-blood NAD+ levels over 12 weeks [10]. A follow-up trial with escalating doses (500–2,000 mg/day) confirmed these findings in a larger cohort [11].

6. Metabolic Health and Insulin Sensitivity

NAD+ influences how your body processes glucose and fat. Several clinical trials have examined its effects on metabolic parameters.

A multicenter, double-blind trial of NMN supplementation in healthy middle-aged adults tested doses of 300, 600, and 900 mg/day for 60 days. All NMN groups showed significantly increased blood NAD+ concentrations compared to placebo (p ≤ 0.001), with the highest levels in the 600 mg and 900 mg groups [12].

Animal studies show more dramatic metabolic improvements — reversed insulin resistance, reduced fat accumulation, improved glucose tolerance [13]. Human trials haven’t fully replicated these effects yet, but the metabolic pathway logic is sound.

7. Neuroprotection and Cognitive Function

NAD+ depletion in the brain correlates with neurodegenerative conditions including Alzheimer’s and Parkinson’s disease. Preclinical models show NAD+ restoration can improve neuronal function and reduce neuroinflammation [4].

Human evidence is still building. The long-COVID trial mentioned above [9] provides some of the strongest clinical data so far, showing NR improved cognitive symptom scores. Larger trials specifically targeting cognitive decline are underway.

For those interested in brain health alongside physical performance, peptides for cognitive function offers additional options that may complement NAD+ therapy.

NAD+ Delivery Methods: IV vs. Oral Precursors

There are several ways to boost NAD+ levels, each with trade-offs.

IV NAD+ Therapy

Direct intravenous infusion of NAD+ bypasses the digestive system entirely. Typical protocols involve 250–500 mg infused over 2–4 hours.

Pros: Highest bioavailability, immediate effect, precise dosing under medical supervision. Cons: Requires clinic visits, more expensive ($250–$1,000+ per session), common side effects during infusion (nausea, flushing, chest tightness).

If you’re considering this route, NAD+ therapy online through telehealth can connect you with providers who offer supervised treatments.

Oral NMN (Nicotinamide Mononucleotide)

NMN is a direct precursor to NAD+. Taken orally, it’s absorbed in the gut and converted to NAD+ in tissues.

Typical doses: 250–900 mg/day Evidence: Multiple RCTs confirm it raises blood NAD+ levels safely [6][12]

Oral NR (Nicotinamide Riboside)

NR takes a slightly different metabolic path to NAD+ but achieves similar results.

Typical doses: 300–2,000 mg/day Evidence: More human trial data than NMN, including the heart failure and long-COVID studies [9][10][11]

Subcutaneous NAD+ Injections

Some clinics offer self-administered NAD+ injections. These provide better bioavailability than oral supplements without the time commitment of IV sessions.

Typical doses: 50–200 mg per injection Frequency: 2–3 times per week

This delivery method follows similar principles to peptide injections and may appeal to those already comfortable with self-injection protocols.

Who Benefits Most From NAD+ Therapy?

Based on current evidence, these groups stand to gain the most:

Adults over 40 — NAD+ decline accelerates after 40, making supplementation more impactful. The gap between current and youthful NAD+ levels widens with each decade.

People with chronic fatigue — If mitochondrial dysfunction contributes to your fatigue, restoring NAD+ addresses a root cause rather than masking symptoms.

Athletes and high-performers — Intense training increases oxidative stress and NAD+ consumption. Supplementation may support faster recovery and sustained output.

Those with metabolic concerns — Early evidence suggests NAD+ supplementation supports insulin sensitivity and metabolic flexibility.

Post-illness recovery — The long-COVID trial [9] demonstrates potential for NAD+ in recovery from infections that affect mitochondrial function.

NAD+ therapy works well alongside other longevity-focused interventions. Many clinics combine it with peptide protocols tailored to individual health goals.

How NAD+ Fits Into Peptide Therapy

NAD+ isn’t a peptide — it’s a coenzyme. But it shows up frequently in peptide therapy discussions because the goals overlap: better energy, slower aging, improved recovery.

Some practitioners combine NAD+ with peptides like:

• CJC-1295/Ipamorelin — for growth hormone optimization alongside cellular energy support. Learn more about this combination in our CJC-1295 + Ipamorelin guide.
• BPC-157 — for tissue repair, which requires adequate cellular energy (NAD+) to function optimally. See our BPC-157 guide.
• MOTS-c — a mitochondrial peptide that works through related metabolic pathways. Read about it in our MOTS-c guide.

The combination approach targets multiple aging pathways simultaneously rather than relying on a single molecule.

If you’re new to these options, our complete list of peptides provides an overview of what’s available and what each one does.

Explore the evidence: See all 10 NAD+ studies in our research database, or browse the full peptide therapy statistics for 2026.

FAQ

How long does it take to feel NAD+ benefits?▼

IV NAD+ therapy often produces noticeable effects within hours — improved mental clarity and energy are commonly reported after the first session. Oral supplementation with NMN or NR typically takes 2–4 weeks of consistent use before most people notice changes. Blood NAD+ levels rise measurably within the first week [12].

Can I take NAD+ supplements without a prescription?▼

NMN and NR are sold as dietary supplements and don’t require a prescription in most cases. However, IV NAD+ therapy and injectable NAD+ require medical supervision and typically a prescription. If you want guidance on the best approach for your situation, a peptide therapy consultation can help.

What’s the difference between NAD+, NMN, and NR?▼

NAD+ is the active molecule your cells use. NMN and NR are precursors — your body converts them into NAD+ after absorption. Think of NMN and NR as raw materials, and NAD+ as the finished product. IV therapy delivers NAD+ directly. Oral supplements provide the building blocks and let your body do the conversion [2].

Is NAD+ therapy safe long-term?▼

Clinical trials of NMN and NR lasting up to 12 weeks have shown no significant safety concerns at doses up to 2,000 mg/day [1][12]. A 2024 systematic review of randomized controlled trials concluded that NAD+ and NADH supplementation is “safe and effective” in humans [14]. Longer-term data is still limited, which is worth acknowledging. For a deeper look at safety considerations, see our NAD+ side effects guide.

Does NAD+ help with weight loss?▼

NAD+ influences metabolic pathways involved in fat oxidation and glucose metabolism, but it’s not a direct weight loss treatment. Animal studies show significant metabolic improvements with NAD+ precursors [13]. Human evidence for weight-specific outcomes is still emerging. For targeted weight management, peptides for weight loss may be more directly effective, though NAD+ can support the metabolic foundation.

Sources

1. Braidy N, Liu Y. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Exp Gerontol. 2020;132:110831. PubMed
2. Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. PubMed
3. Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529-547. PubMed
4. Lautrup S, et al. Roles of NAD+ in Health and Aging. Cold Spring Harb Perspect Med. 2024;14(1):a041193. PubMed
5. Chini EN, et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. Nat Metab. 2020;2(11):1284-1304.
6. Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. 2022;8:5. Nature
7. Fang EF, et al. NAD+ in aging: molecular mechanisms and translational implications. Trends Mol Med. 2017;23(10):899-916.
8. Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471.
9. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. eClinicalMedicine. 2025. The Lancet
10. Zhou B, et al. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J Clin Invest. 2020;130(11):6054-6063.
11. Wang DD, et al. Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fraction. JACC Basic Transl Sci. 2022;7(12):1183-1196. Science
12. Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45:29-43. PubMed
13. Yoshino J, et al. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513-528.
14. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. BioMed Res Int. 2024. PubMed